Anixa Biosciences (ANIX) Return on Sales [ROS] (2010 - 2023)
Anixa Biosciences (ANIX) recorded Return on Sales [ROS] of -5268.42% in fiscal Q4 2023 (quarter ended Oct 31, 2023), up 266.99 percentage points from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Return on Sales [ROS] (2010 - 2023) Analysis & Trends
For FY2023 (ended Oct 31, 2023), Anixa Biosciences reported Return on Sales [ROS] of -5243.33%.
- Annual Return on Sales [ROS] has a five-year change of -3958.92 percentage points (FY2018 to FY2023).
- Across earlier fiscal years, Return on Sales [ROS] came in at -2565.63% in FY2021 and -4756.00% in FY2019 (-3471.59 pp).
- Quarterly Return on Sales [ROS] has ranged from -5535.41% in fiscal Q3 2023 to -435.28% in fiscal Q1 2021 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Anixa Biosciences | 102.02 Mn | 100.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2023 | -5,268.42% |
| Jul 31, 2023 | -5,535.41% |
| Apr 30, 2023 | -1,219.05% |
| Oct 31, 2021 | -2,565.43% |
| Jul 31, 2021 | -2,202.77% |
| Apr 30, 2021 | -1,822.26% |
| Jan 31, 2021 | -435.28% |
| Oct 31, 2019 | -4,756.00% |
| Jul 31, 2019 | -2,476.59% |
| Apr 30, 2019 | -1,037.29% |
| Oct 31, 2018 | -1,284.41% |
| Jul 31, 2018 | -1,546.43% |
| Apr 30, 2018 | -186.79% |
| Oct 31, 2017 | -917.07% |
| Jul 31, 2017 | -477.50% |
| Oct 31, 2016 | -456.65% |
| Jul 31, 2016 | -974.88% |
| Oct 31, 2015 | -10.21% |
| Jul 31, 2015 | -1,569.18% |
| Apr 30, 2015 | -8,532.95% |
API Access
Anixa Biosciences Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();